NASDAQ:BXRX

Baudax Bio, Inc Earning Date

USA |NASDAQ |USD

BXRX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.15 $-0.20 $0.62
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $600.00K $201.00K $68.00K

Baudax Bio, Inc's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

BXRX Earnings Date & History Chart

BXRX Earnings & Revenue Forecast

BXRX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.14 $-0.15 $-0.14
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $-0.74 $-0.74 $-0.74
Dec 2022 2 $-0.49 $-0.49 $-0.49

BXRX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.14 $-0.16 $-0.16
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.74 $-0.80 $-0.80
Dec 2022 0 / 0 $-0.49 $-0.51 $-0.51

BXRX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $1.25M $700.00K $1.80M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $2.25M $1.50M $3.00M
Dec 2022 2 $11.90M $10.30M $13.50M

BXRX Earnings Date & Revenue History

BXRX Earnings History

|
Show More
Show More

BXRX Revenue History

|
Show More
Show More

Baudax Bio, Inc Next Earnings Date & Report

BXRX Next Earnings Date & Report Preview: Sep 2021 (FQ)

BXRX's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 2 analysts, the average EPS estimation for Baudax Bio, Inc's next quarterly earnings is $-0.15, with a low EPS estimation of $-0.16, and a high estimation of $-0.15.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.15, the last 2 month trend is $-0.20, and the 3 month trend is $-0.20.

Based on 3 analysts, the average revenue estimation is $600.00K, with a low revenue estimation of $400.00K, and a high estimation of $800.00K.

Baudax Bio, Inc Previous Earnings Dates & Reports

BXRX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Baudax Bio, Inc's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

BXRX's earnings per share (EPS) was $-0.20, missing the consensus analysts forecast of $-0.19 by -5.26%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -25.93%, and higher than the same period a year before (Jun 2020) by -88.37%.

Revenues were $201.00K, better than the forecast of $201.00K by 0.00%, up by 1.52% from the previous quarter , and down by -42.41% from the same period last year.

The company reported a net income of $-15.33M.

Free cash flow for the quarter was $-24.13M , compared to $-14.08M last quarter and $-11.31M a year before.

BXRX ended the quarter with $8.07M in total debt, a decrease of -13.94% compared to the previous quarter, and a decrease of -7.15% compared to the same quarter a year before.

BXRX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Baudax Bio, Inc's previous annual earnings date was Feb 16, 2021 for its fiscal year ended Dec 31, 2020.

BXRX's earnings per share (EPS) was $-5.22, missing the consensus analysts forecast of $-4.19 by 24.58% , and lower than the previous year's EPS (Dec 2019) by 569.23%.

Revenues were $493.00K.

The company reported a net income of $-76.10M.

Baudax Bio, Inc reported a free cash flow of $-44.70M for its fiscal year, compared to $-51.53M a year ago.

The company ended the fiscal year with $9.48M in total debt, an increase of 1127.04% compared to the previous year.